Mupirocin - Are we in danger of losing it?

Canadian Journal of Infectious Diseases

Volumn 13, Issue 3, 2002, Pages 157-159

  Conly, John M ^a   Johnston, B Lynn ^a  

^a Centre for Antimicrobial Resistance   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; DRUG ABSORPTION; DRUG FORMULATION; DRUG RETENTION; ERADICATION THERAPY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; OINTMENT; PH; PHENOTYPE; PRACTICE GUIDELINE; SHORT SURVEY; SKIN INFECTION;

EID: 0036333355     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/692581     Document Type: Short Survey

References (28)

1. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
2. Mupirocin: A promising new topical antimicrobial agent
3. Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid
4. The emergence of mupirocin resistance: A challenge to infection control and antibiotic prescribing practice
5. Mupirocin: Its chemistry and metabolism
6. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use
7. The laboratory assessment of the antistaphylococcal activity of mupirocin
8. In vitro activity of mupirocin (pseudomonic acid) against clinical isolates of Staphylococcus aureus
9. Heterogeneous location of the mupA high-level mupirocin resistance gene in Staphylococcus aureus
10. Mupirocin resistance in staphylococci: Development and transfer of isoleucyl-tRNA synthetase-mediated resistance in vitro
11. High-level resistance in Staphylococcus aureus: Evidence for two distinct isoleucyl-tRNA synthetases
12. Biochemical basis for resistance in strains of S aureus
13. Bradley SE Effectiveness of mupirocin in the control of methicillin-resistant Staphylococcus aureus
14. Mupirocin-resistant Staphylococcus aureus
15. Mupirocin-resistant Staphylococcus aureus
16. High-level mupirocin resistance among Spanish methicillin-resistant Staphylococcus aureus
17. The prevalence of low-and high-level mupirocin resistance in staphylococci from 19 European hospitals
18. Mupirocin-resistant methicillin-resistant Staphylococcus aureus in Western Australia
19. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment
20. Emergence of mupirocin resistance in multiresistant Staphylococcus aureus clinical isolates belonging to Brazilian epidemic clone III:B:A
21. High incidence of mupirocin-resistant and -susceptible Staphylococcus aureus
22. Interpretive criteria for testing susceptibility of staphylococci to mupirocin
23. Emergence of high-level mupirocin resistance in methicillin-resistant Staphlyococcus aureus isolated from Brazilian university hospitals
24. The epidemiology of mupirocin resistance among methicillin-resistant Staphlyococcus aureus at a Veteran's Affairs hospital
25. Outbreak of mupirocin-resistant staphylococci in a hospital in Warsaw, Poland due to plasmid transmission and clonal spread of several strains
26. Detection of mupirocin reistant staphylococci from patients treated with mupirocin
27. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis
28. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infections